Emerging Growth Conference 92 - 8th May 2026: Immuron Limited (NASDAQ:IMRN)
Immuron Limited (NASDAQ: IMRN), is a biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
Keynote speaker: Steve Lydeamore, CEO
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Immuron a question about this update.